🔴 SKIN is trading 5.2% down today on profit-taking after its recent FDA-driven surge

SKIN is trading at $1.05 (-5.23%) as investors lock in gains following a sharp rally triggered by FDA clearance for its SkinStylus device.

• The stock previously surged 47.04% to reach $1.11 on July 7, marking a significant regulatory milestone that is now seeing a natural pullback.
• Broader market weakness is adding to the downward pressure, with major U.S. indexes falling approximately 0.8% as overall risk appetite softens.